TN2013000135A1 - Solid state forms of a potent hcv inhibitor - Google Patents

Solid state forms of a potent hcv inhibitor

Info

Publication number: TN2013000135A1
Authority: TN; Tunisia
Prior art keywords: solid state; state forms; hcv inhibitor; potent hcv; potent
Prior art date: 2011-09-23

Application number

TNP2013000135A

Other languages

English (en)

Inventor

Rolf-Stefan Brickl

Shirlynn Chen

Jihchin Chung

Mayur Suryakant Dudhedia

Danping Li

Siddharthya Mujumdar

Chitra Telang

Richard Varsolona

Zeren Wang

Zhi-Hui Lu

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-09-23

Filing date

2013-03-27

Publication date

2014-06-25

2011-09-23 Priority claimed from PCT/US2011/052869 external-priority patent/WO2012044520A1/fr

2013-03-27 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2014-06-25 Publication of TN2013000135A1 publication Critical patent/TN2013000135A1/fr

Landscapes

Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

TNP2013000135A 2011-09-23 2013-03-27 Solid state forms of a potent hcv inhibitor TN2013000135A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2011/052869 WO2012044520A1 (fr)	2010-09-30	2011-09-23	Formes solides d'un inhibiteur puissant du vhc

Publications (1)

Publication Number	Publication Date
TN2013000135A1 true TN2013000135A1 (en)	2014-06-25

Family

ID=54360803

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TNP2013000135A TN2013000135A1 (en)	2011-09-23	2013-03-27	Solid state forms of a potent hcv inhibitor

Country Status (1)

Country	Link
TN (1)	TN2013000135A1 (fr)

2013
- 2013-03-27 TN TNP2013000135A patent/TN2013000135A1/fr unknown

Similar Documents

Publication	Publication Date	Title
MY153093A (en)	2014-12-31	Crystalline forms of a 2-thiazolyl-4-quinolinyl-oxy derivative, a potent hcv inhibitor
EA026667B9 (ru)	2017-07-31	Фармацевтическая композиция для лечения вируса гепатита с
PH12015502056A1 (en)	2016-09-19	Benzothiazole compounds and their pharmaceutical use
UA113956C2 (xx)	2017-04-10	Похідні піримідину для лікування вірусних інфекцій
MD20140136A2 (ro)	2015-05-31	Inhibitori ai virusului hepatic C
PH12013500015A1 (en)	2013-02-18	2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds
PH12014501134A1 (en)	2014-07-28	2',4'-difluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication
PH12013501543A1 (en)	2013-09-23	Hepatitis c virus inhibitors
TN2012000358A1 (en)	2014-01-30	Hepatitis c virus inhibitors
EP2555622A4 (fr)	2013-09-18	Inhibiteurs du virus de l'hépatite c
MY160130A (en)	2017-02-28	Hepatitis c virus inhibitors
MX2012008221A (es)	2012-08-17	Inhibidores de virus flaviviridae.
MX2012000959A (es)	2012-03-06	Inhibidores de los virus flaviviridae.
MX2012008211A (es)	2012-08-08	Inhibidores de virus flaviviridae.
IN2012DN01855A (fr)	2015-08-21
PH12014501283A1 (en)	2014-09-08	4`-azido, 3``-fluoro substituted nucleoside derivatives as inhibitors of hcv rna replication
MX2013001237A (es)	2013-05-28	Compuestos inhibidores del virus de la hepatitis c.
WO2013059278A3 (fr)	2014-05-22	Inhibiteurs du virus de l'hépatite c
WO2011150190A3 (fr)	2012-03-08	Composés inhibiteurs du virus de l'hépatite c (hcv) et leurs procédés d'utilisation
MY167881A (en)	2018-09-26	Process for preparing antiviral compounds
PH12013502177A1 (en)	2014-01-13	Hepatitis c virus inhibitors
JO3281B1 (ar)	2018-09-16	مركبات بينزوفوران لمعالجة عدوى فيروس إلتهاب الكبد الوبائي
MX360161B (es)	2018-10-09	Proceso para preparar compuestos antiviricos.
PH12013500558A1 (en)	2013-05-06	Solid state forms of a potent hcv inhibitor
MY169288A (en)	2019-03-21	Process for preparing an antiviral compound